Remifentanil is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia.
Remifentanil is indicated for provision of analgesia in mechanically ventilated intensive care patients 18 years of age and older.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.